Abbott Laboratories (ABT) engages in the discovery, development, manufacture, and sale of a line of health care and pharmaceutical products. Below you will find selected information from Value Line. Use the Value Line estimated 2012 figures as the actual year-end figures for the company. The beta reported was .8 and the risk-free rate was 3.63 percent. Assume a market risk premium of 6 percent.

The high and low share price each year were:

		2008		2009		2010		2011		2012
High	$	63	$	63.9	$	60.9	$	66.7	$	57.4
Low		53		51.7		41.8		45.8		42.5

Using the P/E, P/CF, and P/S ratios, estimate the 2013 share price for Abbott Laboratories. Use the average stock price each year to calculate the price ratios. (Do not round intermediate calculations. Round your answers to 2 decimal places. Omit the "$" sign in your response.)

Price ratio
P/E	$ 67.12 67.12 Incorrect
P/CF	$ 65.92 65.92 Incorrect
P/S	$ 48.04 48.04 Incorrect

Question 1 of 8 Total 1 of